Article Review: Molecular Study for Mutation of N-gene and S-gene COVID-19 Virus

Authors

  • Abeer Ali Marhoon AL-Rafidian University College, Baghdad. IRAQ.
  • Zina F. H. AL-Obaidi College of Biotechnology, AL-Nahrian University, Baghdad, IRAQ.

DOI:

https://doi.org/10.31033/ijrasb.9.1.4

Keywords:

COVID-19 mutation, SARS-CoV, Spike glycoprotein, S-gene mutation, N-gene Mutation, COVID-19 receptor binding domain, COVID-19 antigens

Abstract

Thousands of individuals are affected every day by the current covid-19 pandemic, which is caused by a novel coronavirus called SARSCoV2. As a result, medicines and vaccines that are effective against all SARSCoV2 subtypes are critical today. Viral genome mutations are prevalent, and they can affect the encoded proteins, resulting in varying levels of detection and illness treatment effectiveness. Despite its clinical relevance, the SARS-CoV-2 gene set remains uncertain, making COVID-19 biology difficult to understand. A single type of mutation in the S gene that was changed the anticodon 614 from aspartic acid to glycine (D614G) consequence in increased virus infection. Herein, we report the gene mutation of structural proteins particularly spike and nucleocapsid proteins in viral genome. The overall prevalence of S and N gene mutations in SARS-CoV-2 were investigated. Among the structural proteins, our findings suggest that nucleocapsid had the highest mutation density, whereas Spike D614G was the most prevalent 93.9 %, found largely in genomes worldwide. These findings indicate that while designing diagnostics tools and therapeutic alternatives, the virus genotype in a certain community should be taken into account.

Downloads

Download data is not yet available.

References

Bakhshandeh, B., et al., Mutations in SARS-CoV-2; Consequences in structure, function, and pathogenicity of the virus. Microbial Pathogenesis, 2021: p. 104831.

Lauring, A. and E. Hodcroft, Variantes genéticas del SARS-CoV-2:¿ qué significan. JAMA, 2021. 325: p. 529-531.

Letko, M., A. Marzi, and V. Munster, Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat Microbiol. 2020; 5: 562–9. PUBMED.

Perlman, S. and K. McIntosh, 155-Coronaviruses, Including Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), in Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 2020, University of Iowa. p. 2072-2080. e3.

Lam, T.T.-Y., et al., Identification of 2019-nCoV related coronaviruses in Malayan pangolins in southern China. bioRxiv 2020. Google Scholar, 2020.

Sohrabi, C., et al., World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International journal of surgery, 2020. 76: p. 71-76.

Andersen, K.G., et al., A origem proximal do SARS-CoV-2. Nat Med, 2020. 26(4): p. 450-452.

Ardura, M., et al., Addressing the impact of the coronavirus disease 2019 (COVID-19) pandemic on hematopoietic cell transplantation: learning networks as a means for sharing best practices. Biology of Blood and Marrow Transplantation, 2020. 26(7): p. e147-e160.

Qiu, H., et al., Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: an observational cohort study. The Lancet infectious diseases, 2020. 20(6): p. 689-696.

Belouzard, S., et al., Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 2012. 4(6): p. 1011-1033.

Zhou, P., et al., & Shi, ZL (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 579(7798): p. 270-273.

Ahmadpour, D., P. Ahmadpoor, and L. Rostaing, Impact of circulating SARS-CoV-2 mutant G614 on the COVID-19 pandemic. Iran J Kidney Dis, 2020. 14(5): p. 331-334.

Walls, A.C., et al., Cryo-electron microscopy structure of a coronavirus spike glycoprotein trimer. Nature, 2016. 531(7592): p. 114-117.

Ortega, J.T., et al., Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis. EXCLI journal, 2020. 19: p. 410.

Rambaut, A., et al., A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020 Jul 15; 1–5.

Kaufmann, S.H., et al., Host-directed therapies for bacterial and viral infections. Nature reviews Drug discovery, 2018. 17(1): p. 35-56.

Grubaugh, N.D., M.E. Petrone, and E.C. Holmes, We shouldn’t worry when a virus mutates during disease outbreaks. Nature microbiology, 2020. 5(4): p. 529-530.

Pachetti, M., et al., Impact of lockdown on Covid-19 case fatality rate and viral mutations spread in 7 countries in Europe and North America. Journal of Translational Medicine, 2020. 18(1): p. 1-7.

Flores-Alanis, A., et al., Molecular epidemiology surveillance of SARS-CoV-2: mutations and genetic diversity one year after emerging. Pathogens, 2021. 10(2): p. 184.

Chen, Y., et al., Structure analysis of the receptor binding of 2019-nCoV. Biochemical and biophysical research communications, 2020. 525(1): p. 135-140.

Chan, J.F.-W., et al., Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerging microbes & infections, 2020. 9(1): p. 221-236.

Li, F., Structure, function, and evolution of coronavirus spike proteins. Annual review of virology, 2016. 3: p. 237-261.

Peck, K.M. and A.S. Lauring, Complexities of viral mutation rates. Journal of virology, 2018. 92(14): p. e01031-17.

of the International, C.S.G., The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nature microbiology, 2020. 5(4): p. 536.

Wu, A., et al., Genome composition and divergence of the novel coronavirus (2019-nCoV). 2020.

Kim, D., et al., The architecture of SARS-CoV-2 transcriptome. Cell, 2020. 181(4): p. 914-921. e10.

Chen, Y., Q. Liu, and D. Guo, Emerging coronaviruses: genome structure, replication, and pathogenesis. Journal of medical virology, 2020. 92(4): p. 418-423.

Wu, A., et al., Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China. Cell host & microbe, 2020. 27(3): p. 325-328.

Astuti, I., Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(4): p. 407-412.

Yin, C., Genotyping coronavirus SARS-CoV-2: methods and implications. Genomics, 2020. 112(5): p. 3588-3596.

Troyano-Hernáez, P., R. Reinosa, and Á. Holguín, Evolution of SARS-CoV-2 envelope, membrane, nucleocapsid, and spike structural proteins from the beginning of the pandemic to September 2020: a global and regional approach by epidemiological week. Viruses, 2021. 13(2): p. 243.

Satarker, S. and M. Nampoothiri, Structural proteins in severe acute respiratory syndrome coronavirus-2. Archives of medical research, 2020. 51(6): p. 482-491.

Yang, J., et al., Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Nature communications, 2020. 11(1): p. 1-10.

Huang, Y., et al., Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacologica Sinica, 2020. 41(9): p. 1141-1149.

Andersen, K.G., et al., The proximal origin of SARS-CoV-2. Nature medicine, 2020. 26(4): p. 450-452.

Chang, T.-J., et al., Genomic analysis and comparative multiple sequences of SARS-CoV2. Journal of the Chinese Medical Association, 2020. 83(6): p. 537-543.

Badua, C.L.D., K.A.T. Baldo, and P.M.B. Medina, Genomic and proteomic mutation landscapes of SARS‐CoV‐2. Journal of medical virology, 2021. 93(3): p. 1702-1721.

Kang, S., et al., Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites. Acta Pharmaceutica Sinica B, 2020. 10(7): p. 1228-1238.

Peng, T.Y., K.R. Lee, and W.Y. Tarn, Phosphorylation of the arginine/serine dipeptide‐rich motif of the severe acute respiratory syndrome coronavirus nucleocapsid protein modulates its multimerization, translation inhibitory activity and cellular localization. The FEBS journal, 2008. 275(16): p. 4152-4163.

Andres, C., et al., Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients. Emerging Microbes & Infections, 2020. 9(1): p. 1900-1911.

Becerra‐Flores, M. and T. Cardozo, SARS‐CoV‐2 viral spike G614 mutation exhibits higher case fatality rate. International journal of clinical practice, 2020. 74(8): p. e13525.

Yuan, F., et al., Global SNP analysis of 11,183 SARS‐CoV‐2 strains reveals high genetic diversity. Transboundary and emerging diseases, 2021. 68(6): p. 3288-3304.

Gupta, A.M., J. Chakrabarti, and S. Mandal, Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants. Microbes and infection, 2020. 22(10): p. 598-607.

Islam, M.R., et al., Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide implicates heterogeneity. Scientific reports, 2020. 10(1): p. 1-9.

Kim, S., et al., The progression of sars coronavirus 2 (sars-cov2): mutation in the receptor binding domain of spike gene. Immune network, 2020. 20(5).

Nagy, Á., S. Pongor, and B. Győrffy, Different mutations in SARS-CoV-2 associate with severe and mild outcome. International journal of antimicrobial agents, 2021. 57(2): p. 106272.

Benvenuto, D., et al., Evidence for mutations in SARS‐CoV‐2 Italian isolates potentially affecting virus transmission. Journal of medical virology, 2020. 92(10): p. 2232-2237.

Cusi, M.G., et al., Whole-genome sequence of SARS-CoV-2 isolate Siena-1/2020. Microbiology Resource Announcements, 2020. 9(39): p. e00944-20.

Micheli, V., et al., Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase. Journal of Medical Virology, 2021. 93(3): p. 1752-1757.

Ip, J.D., et al., Intra-host non-synonymous diversity at a neutralizing antibody epitope of SARS-CoV-2 spike protein N-terminal domain. Clinical Microbiology and Infection, 2021. 27(9): p. 1350. e1-1350. e5.

Leung, K.S.-S., et al., Territorywide study of early coronavirus disease outbreak, Hong Kong, China. Emerging infectious diseases, 2021. 27(1): p. 196.

Jacob, J.J., et al., Genomic evolution of severe acute respiratory syndrome Coronavirus 2 in India and vaccine impact. Indian journal of medical microbiology, 2020. 38(2): p. 210-212.

Devendran, R., M. Kumar, and S. Chakraborty, Genome analysis of SARS-CoV-2 isolates occurring in India: Present scenario. Indian journal of public health, 2020. 64(6): p. 147.

Hassan, S.S., et al., Missense mutations in SARS-CoV2 genomes from Indian patients. Genomics, 2020. 112(6): p. 4622-4627.

Saha, O., M.S. Hossain, and M.M. Rahaman, Genomic exploration light on multiple origin with potential parsimony-informative sites of the severe acute respiratory syndrome coronavirus 2 in Bangladesh. Gene reports, 2020. 21: p. 100951.

Kozlovskaya, L., et al., Isolation and phylogenetic analysis of SARS-CoV-2 variants collected in Russia during the COVID-19 outbreak. International Journal of Infectious Diseases, 2020. 99: p. 40-46.

Volz, E., et al., Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity. Cell, 2021. 184(1): p. 64-75. e11.

Ziegler, K., et al., SARS-CoV-2 samples may escape detection because of a single point mutation in the N gene. Eurosurveillance, 2020. 25(39): p. 2001650.

Zhang, Y., et al., Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020. Biosafety and Health, 2020. 2(4): p. 202-205.

Chen, J., et al., Epidemiological and Genomic Analysis of SARS-CoV-2 in 10 Patients From a Mid-Sized City Outside of Hubei, China in the Early Phase of the COVID-19 Outbreak. Frontiers in public health, 2020. 8.

Du, P., et al., Genomic surveillance of COVID-19 cases in Beijing. Nature communications, 2020. 11(1): p. 1-9.

Zuckerman, N.S., et al., Comprehensive analyses of SARS-CoV-2 transmission in a public health virology laboratory. Viruses, 2020. 12(8): p. 854.

Bartolini, B., et al., SARS-CoV-2 phylogenetic analysis, Lazio region, Italy, February–march 2020. Emerging infectious diseases, 2020. 26(8): p. 1842.

Surleac, M., et al., Molecular epidemiology analysis of SARS-CoV-2 strains circulating in Romania during the first months of the pandemic. Life, 2020. 10(8): p. 152.

Taboada, B., et al., Genomic analysis of early SARS-CoV-2 variants introduced in Mexico. Journal of virology, 2020. 94(18): p. e01056-20.

McNamara, R.P., et al., High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States. Cell reports, 2020. 33(5): p. 108352.

Jenjaroenpun, P., et al., Two SARS-CoV-2 genome sequences of isolates from rural US patients harboring the D614G mutation, obtained using Nanopore sequencing. Microbiology Resource Announcements, 2020. 10(1): p. e01109-20.

Barrett, C., et al., Multiscale feedback loops in SARS-CoV-2 viral evolution. Journal of Computational Biology, 2021. 28(3): p. 248-256.

Hartley, P., et al., Genomic surveillance revealed prevalence of unique SARS-CoV-2 variants bearing mutation in the RdRp gene among Nevada patients. medRxiv, 2020.

Wang, R., et al., Decoding asymptomatic COVID-19 infection and transmission. The journal of physical chemistry letters, 2020. 11(23): p. 10007-10015.

Akter, S., et al., Coding-complete genome sequences of three SARS-CoV-2 strains from Bangladesh. Microbiology Resource Announcements, 2020. 9(39): p. e00764-20.

Parvez, M.S.A., et al., Genetic analysis of SARS-CoV-2 isolates collected from Bangladesh: Insights into the origin, mutational spectrum and possible pathomechanism. Computational biology and chemistry, 2021. 90: p. 107413.

Ghosh, N., et al., Genome-wide analysis of 10664 SARS-CoV-2 genomes to identify virus strains in 73 countries based on single nucleotide polymorphism. Virus research, 2021. 298: p. 198401.

Demir, A.B., et al., Identification of the nucleotide substitutions in 62 SARS-CoV-2 sequences from Turkey. Turkish Journal of Biology, 2020. 44(SI-1): p. 178-184.

Gong, Y.-N., et al., SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East. Emerging microbes & infections, 2020. 9(1): p. 1457-1466.

Jary, A., et al., Evolution of viral quasispecies during SARS-CoV-2 infection. Clinical Microbiology and Infection, 2020. 26(11): p. 1560. e1-1560. e4.

Laamarti, M., et al., Genome sequences of six SARS-CoV-2 strains isolated in morocco, obtained using oxford nanopore minion technology. Microbiology Resource Announcements, 2020. 9(32): p. e00767-20.

Ling, J., et al., Spatio-temporal mutational profile appearances of Swedish SARS-CoV-2 during the early pandemic. Viruses, 2020. 12(9): p. 1026.

Velasco, J.M., et al., Coding-complete genome sequences of 23 SARS-CoV-2 samples from the Philippines. Microbiology Resource Announcements, 2020. 9(43): p. e01031-20.

Aljahdali, B.A., VITAMIN D STATUS AND AUTOIMMUNE DISEASE (HASHIMOTO’S THYROIDITIS) IN SAUDI ARABIAN WOMEN. 2018.

Botelho, I.M.B., et al., Vitamin D in Hashimoto’s thyroiditis and its relationship with thyroid function and inflammatory status. Endocrine journal, 2018. 65(10): p. 1029-1037.

Roman, G.S., et al. Vitamin D deficiency and Hashimoto’s thyroiditis. in Endocrine Abstracts. 2021. Bioscientifica.

Pachetti, M., et al., Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant. Journal of translational medicine, 2020. 18(1): p. 1-9.

Yao, H.-P., et al., Patient-derived mutations impact pathogenicity of SARS-CoV-2. 2020.

Korber, B., et al., Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2. BioRxiv, 2020.

Khailany, R.A., M. Safdar, and M. Ozaslan, Genomic characterization of a novel SARS-CoV-2. Gene reports, 2020. 19: p. 100682.

Ahamad, S., H. Kanipakam, and D. Gupta, Insights into the structural and dynamical changes of spike glycoprotein mutations associated with SARS-CoV-2 host receptor binding. Journal of Biomolecular Structure and Dynamics, 2020: p. 1-13.

Li, Q., et al., The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell, 2020. 182(5): p. 1284-1294. e9.

Shang, J., et al., Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences, 2020. 117(21): p. 11727-11734.

Bhattacharyya, C., et al., Global spread of SARS-CoV-2 subtype with spike protein mutation D614G is shaped by human genomic variations that regulate expression of TMPRSS2 and MX1 genes. BioRxiv, 2020.

Yurkovetskiy, L., et al., Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell, 2020. 183(3): p. 739-751. e8.

Tsai, P.-H., et al., Genomic variance of Open Reading Frames (ORFs) and Spike protein in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Journal of the Chinese Medical Association, 2020. 83(8): p. 725.

Korber, B., et al., Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell, 2020. 182(4): p. 812-827. e19.

Yap, P.S.X., et al., An overview of the genetic variations of the SARS-CoV-2 genomes isolated in Southeast Asian countries. 2020.

Downloads

Published

2022-01-31

How to Cite

Marhoon, A. A. ., & AL-Obaidi, Z. F. H. . (2022). Article Review: Molecular Study for Mutation of N-gene and S-gene COVID-19 Virus. International Journal for Research in Applied Sciences and Biotechnology, 9(1), 34–44. https://doi.org/10.31033/ijrasb.9.1.4